Onconova Therapeutics prices upsized IPO at $15, above the range

Comment

Shutterstock photo

Onconova Therapeutics, a biotech focused on developing drug candidates for cancer and related diseases, raised $78 million by offering 5.2 million shares at $15, above the range of $12 to $14. The Newtown, PA-based company had originally planned to offer 4.6 million shares. Onconova Therapeutics, which now has a market cap of approximately $310 million, will list on the NASDAQ under the symbol ONTX. Citi and Leerink Swann acted as lead managers on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs


More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com